Clinical Trial Update: Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating diquafosol tetrasodium ophthalmic solution for Dry Eye Disease has completed. The provided snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Diquafosol Tetrasodium Ophthalmic Solution (diquafosol tetrasodium)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED